Amgen Inc (AMGN):企業の財務・戦略的SWOT分析

◆英語タイトル:Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH3778FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:72
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Amgen Inc (AMGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to treat patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncology/hematology, inflammation, bone health, neuroscience and nephrology. The company develops products by using advanced human genetics to unravel the difficulties of disease and understand the fundamentals of human biology. Amgen sells products primarily to pharmaceutical wholesale distributors in the US. It also markets certain products directly to consumers by direct-to-consumer channels such as print, television and online media. Amgen is headquartered in Thousand Oaks, California, the US.

Amgen Inc Key Recent Developments

Mar 05,2021: Amgen signs agreement to acquire Five Prime Therapeutics for $1.9bn
Mar 03,2021: Amgen announces 2021 second quarter dividend
Feb 03,2021: Amgen sponsors Golden Ticket at BioLabs LA at The Lundquist Institute to help accelerate life science startups
Feb 02,2021: Amgen Reports Fourth Quarter And Full Year 2020 Financial Results
Jan 22,2021: Ten leading bioPharma companies announce formation of Accumulus Synergy to develop global data sharing platform

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Amgen Inc – Key Facts
Amgen Inc – Key Employees
Amgen Inc – Key Employee Biographies
Amgen Inc – Major Products and Services
Amgen Inc – History
Amgen Inc – Company Statement
Amgen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Amgen Inc – Business Description
Business Segment: Human Therapeutics
Overview
Performance
Key Stats
Business Segment: Other Revenues
Overview
Performance
Geographical Segment: Rest of the world (ROW)
Performance
Geographical Segment: United States
Performance
R&D Overview
Amgen Inc – Corporate Strategy
Amgen Inc – SWOT Analysis
SWOT Analysis – Overview
Amgen Inc – Strengths
Amgen Inc – Weaknesses
Amgen Inc – Opportunities
Amgen Inc – Threats
Amgen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amgen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 03, 2021: Amgen sponsors Golden Ticket at BioLabs LA at The Lundquist Institute to help accelerate life science startups
Feb 02, 2021: Amgen Reports Fourth Quarter And Full Year 2020 Financial Results
Jan 22, 2021: Ten leading bioPharma companies announce formation of Accumulus Synergy to develop global data sharing platform
Jan 12, 2021: Amgen to showcase next frontier of innovation in lung cancer therapies at WCLC 2020
Jan 11, 2021: Amgen to achieve carbon neutrality by 2027
Jan 11, 2021: GRAIL announces collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to evaluate cancer early detection technology for minimal residual disease
Dec 17, 2020: Amgen awards two local biotech start-ups with Golden Ticket To LabCentral
Dec 16, 2020: Amgen to transfer listing of debt securities to Nasdaq
Dec 15, 2020: American College of Cardiology to collaborate with Amgen, Veradigm to optimize ACS care
Dec 10, 2020: AHF blasts Amgen over drug restrictions; Asks Biden Administration to sanction it and others
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Amgen Inc, Key Facts
Amgen Inc, Key Employees
Amgen Inc, Key Employee Biographies
Amgen Inc, Major Products and Services
Amgen Inc, History
Amgen Inc, Other Locations
Amgen Inc, Subsidiaries
Amgen Inc, Joint Venture
Amgen Inc, Key Competitors
Amgen Inc, Ratios based on current share price
Amgen Inc, Annual Ratios
Amgen Inc, Annual Ratios (Cont...1)
Amgen Inc, Annual Ratios (Cont...2)
Amgen Inc, Interim Ratios
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amgen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Amgen Inc (AMGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hosken Consolidated Investments Ltd (HCI):企業の財務・戦略的SWOT分析
    Hosken Consolidated Investments Ltd (HCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Healthsense Inc-医療機器分野:企業M&A・提携分析
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • Valero Energy Corporation:企業の戦略・SWOT・財務情報
    Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Taghleef Industries L.L.C.:企業の戦略・SWOT・財務分析
    Taghleef Industries L.L.C. - Strategy, SWOT and Corporate Finance Report Summary Taghleef Industries L.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Avista Corporation:企業の戦略・SWOT・財務分析
    Avista Corporation - Strategy, SWOT and Corporate Finance Report Summary Avista Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sharp Corporation:企業の戦略・SWOT・財務情報
    Sharp Corporation - Strategy, SWOT and Corporate Finance Report Summary Sharp Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bioceptive Inc-医療機器分野:企業M&A・提携分析
    Summary Bioceptive Inc (Bioceptive) is a medical device company which provides women health solutions. The company offers products such as intrauterine devices, intuitive IUD insertion systems and IUD inserters, among others. Its intrauterine devices offer less traumatic cervical engagement and entr …
  • Southern Maryland Electric Cooperative Inc:企業の戦略的SWOT分析
    Southern Maryland Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • CNH Industrial NV:企業の戦略・SWOT・財務情報
    CNH Industrial NV - Strategy, SWOT and Corporate Finance Report Summary CNH Industrial NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Dow Chemical Co (DOW)-石油・ガス分野:企業M&A・提携分析
    Summary The Dow Chemical Company (Dow) is a diversified chemical company. Its businesses encompass specialty chemicals, advanced materials, agrosciences and plastics. The company manufactures and supplies products used primarily as raw materials in the manufacture of customer products and services. …
  • Aviva plc:企業のM&A・事業提携・投資動向
    Aviva plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aviva plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • ThreeD Capital:企業のM&A・事業提携・投資動向
    ThreeD Capital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThreeD Capital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Ocular Therapeutix Inc (OCUL):企業の製品パイプライン分析2018
    Summary Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company’s products include DEXTENZA, sustained release travoprost and posterior …
  • TFS International AB:製薬・医療:M&Aディール及び事業提携情報
    Summary TFS International AB (TFS International) is a contract research organization that provides clinical development solutions. The organization through its business areas, TFS Develop and TFS People, provides various services worldwide including clinical development planning, regulatory affairs, …
  • Hyposwiss Private Bank Geneve SA:企業の戦略・SWOT・財務情報
    Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report Summary Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • WPG Holdings Limited:企業の戦略・SWOT・財務情報
    WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • TransAlta Corp:企業の発電所・SWOT分析2018
    TransAlta Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • BayWa AG:戦略・SWOT・企業財務分析
    BayWa AG - Strategy, SWOT and Corporate Finance Report Summary BayWa AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Harpoon Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Harpoon Therapeutics Inc (Harpoon Therapeutics) is a biotechnology company that offers solutions for immune-oncology diseases. The company provides products portfolio such as of HPN424, prostate specific antigen and harnesses a technology named TriTAC technology. It employs TriTAC technology …
  • AMVIG Holdings Ltd.:企業の戦略・SWOT・財務情報
    AMVIG Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary AMVIG Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆